Mo Li on PARP inhibitors

eBioMedicine in conversation with - A podcast by The Lancet Group

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Education

Dr. Mo Li from Peking University Third Hospital discusses his publication "PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response". Read the full article: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00164-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedic...